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The brain has been commonly regarded as a “tissue behind walls.” Appearance of immune
cells in the brain has been taken as a sign of pathology. Moreover, since inﬁltrating
monocyte-derived macrophages and activated resident microglia were indistinguishable by
conventionalmeans,bothpopulationswereconsideredtogetherasinﬂammatorycellsthat
should be mitigated.Yet, because the microglia permanently reside in the brain, attributing
to them negative properties evoked an ongoing debate; why cells that are supposed to be
the brain guardians acquire only destructive potential? Studies over the last two decades
in the immune arena in general, and in the context of central nervous system pathology
in particular, have resulted in a paradigm shift toward a more balanced appreciation of the
contributions of immune cells in the context of brain maintenance and repair, and toward
the recognition of distinct roles of resident microglia and inﬁltrating monocyte-derived
macrophages.
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DIFFERENTIAL MONONUCLEAR PHAGOCYTE ORIGINS
The mononuclear phagocyte system–at e r mc o i n e db yvan Furth
et al. (1972) – is known today to comprise monocytes, den-
dritic cells (DCs), and macrophages, as well as their respective
committedbonemarrow(BM)progenitors.Mononuclearphago-
cytes can arise via two exclusive developmental routes (Orkin
and Zon, 2008). Most peripheral mononuclear phagocytes are
descended from BM-derived cells formed as part of ongoing
deﬁnitive hematopoiesis. A major breakthrough in deﬁning this
developmental pathway was the identiﬁcation of a clonotypic
BM-resident founder cell, termed the macrophage-DC precursor
(MDP), that can give rise to peripheral mononuclear phago-
cytes while having lost granulocyte potential (Fogg et al., 2006).
MDPs differentiate within the BM into monocytes (Varol et al.,
2007) and into dedicated DC precursors, the pre-DCs, that exit
to the circulation to enable the repopulation of peripheral tissue
macrophages and DCs, respectively. As opposed to the ephemeral
DCs, peripheral macrophage populations are however heteroge-
neous with respect to their turnover rate,and thus,in their steady
state, rely to a varying degree on renewal by BM-derived precur-
sors, e.g., monocyte input (Landsman et al., 2007; Varol et al.,
2007). Under inﬂammatory conditions, most resident microglia
arecomplementedbyrecruitedmonocytesthatdifferentiateinsitu
into macrophages (Ajami et al., 2011). However, the contribution
of these cells is often transient (Ajami et al., 2011). Moreover,
in certain scenarios, such as parasite-driven Th2 inﬂammation,
tissue-resident macrophage populations were recently shown to
even expand locally without any monocyte inﬂux (Jenkins et al.,
2011).
As exempliﬁed by the brain microglia (Alliot et al., 1999; Gin-
houx et al., 2010), mononuclear phagocytes can also arise during
earlydevelopment(aroundembryonicday7.5)asaresultof prim-
itive hematopoiesis occurring in extra-embryonic tissue (Orkin
and Zon, 2008). After seeding the tissue that is their ﬁnal desti-
nation, these primitive macrophage-derived cells can – as is the
case for the secluded microglia – maintain themselves through
longevity coupled with limited self-renewal. Thus,these compart-
ments remain independent of monocytic input throughout adult
life (Ajami et al., 2007; Mildner et al., 2007; Shechter et al., 2009;
Ginhoux et al., 2010). This alternative pathway might encode
functional specialization. However, to what extent it applies to
macrophage populations other than the brain microglia, remains
currently unknown and will have to await future fate mapping
studies.
THE MYSTERY OF THE ROLE OF MONOCYTE-DERIVED
MACROPHAGES FOLLOWING STERILE CNS INJURY
Extensive comparison of the responses of the peripheral and
central nervous system (CNS) to axonal injury has revealed
that recruitment of blood-derived cells to injured peripheral
nerves is more pronounced than to the CNS (Perry et al., 1993).
Opinions differed, however, regarding the interpretation of this
ﬁnding (Rapalino et al., 1998; Schwartz et al., 1999; Shechter
et al., 2009; London et al., 2011). Insight into “sterile” (non-
infectious) injuries outside the CNS (DiPietro, 1995) and the
assumption that recruited cells may be beneﬁcial though their
numbers might be insufﬁcient for optimal repair, let to the sug-
gestion that introduction of blood-derived macrophages with the
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FIGURE 1 | Differential origins of microglia and monocyte-derived brain
macrophages. Microglia derive from macrophages that arise from primitive
hematopoiesis in the yolk sac,The primitive macrophages seed the
developing brain and expand to give rise to the microglia, which subsequently
maintains itself through longevity and limited self-renewal. Upon injury, the
brain recruits monocytes that differentiate locally into monocyte-derived
macrophages and transiently complement the brain mononuclear phagocyte
compartment. Monocytes are generated in the BM from macrophage-DC
precursors (MDPs) that are constantly replenished from self-renewing
hematopoietic stem cells (HSCs) which arose from deﬁnitive hematopoiesis.
correct phenotype, at the right time, and to the correct loca-
tion following CNS injury could promote repair. Indeed, in a
model of spinal cord injury, it was demonstrated that “alterna-
tively activated”blood macrophages, when locally transplanted at
the margin of a spinal cord lesion, resulted in improved recov-
ery (Rapalino et al., 1998). The success of such macrophage
transplantation was found to be dependent on the site of their
injection (no effect was found when cells were administered at
the center of the lesion or far from its margins), the number
of injected cells, and the time elapsed between the injury and
the injection (Schwartz and Yoles, 2006). The results of these
manipulations were initially puzzling,primarily due to the lack of
appreciation of macrophage heterogeneity (Gordon, 2003; Gor-
don and Taylor, 2005) by neuroscientists (Popovich et al., 1999;
Mabon et al., 2000). Since the site of injury becomes sponta-
neously overwhelmed with locally activated microglia, the idea of
deriving therapeutic beneﬁt by adding additional blood-derived
macrophages seemed contrary to common logic. Subsequent
studies from several laboratories regarding the roles of various
macrophage populations further complicated the picture, as the
researchersprimarilystudiedmacrophagesactivatedinvitro using
products of bacteria or yeast, assuming that such inﬂammatory
cells mimic strongly activated macrophages. However, activating
agents differ not only in their strength of activation, but also
in the functional state that they induce; thus, macrophages acti-
vated by yeast or bacterial cell wall components, such as zymosan
or LPS, do not necessarily represent cells activated following
“sterile”injury.
Additional missing pieces in the puzzle of the role of
macrophages following CNS injury were the realization that
distinct immune activities might be needed following the
insult for tissue rescue/protection (Shechter et al., 2009) and
restoration/regeneration (Benowitz and Yin, 2010; Benowitz and
Popovich, 2011), and that although activated microglia and
monocyte-derived macrophages share morphology and phe-
notypes, they might display distinct activities at critical time
points following the insult (Shechter et al., 2009). These facts
were belatedly accepted when standard histological or immuno-
histochemical techniques of limited resolution were comple-
mented by new genetic approaches enabling the tracking of cell
origins and fates.
DIFFERENTIAL CONTRIBUTIONS OF ACTIVATED RESIDENT
MICROGLIA AND INFILTRATING MONOCYTE-DERIVED
MACROPHAGES TO THE RECOVERY FROM ACUTE SPINAL
CORD INJURY
As outlined above,it is becoming clear that the resident microglia
compartmentisderivedfromprimitivemacrophagesthatenterthe
CNS during embryonic development; this compartment remains
independent of monocytic input throughout life (Figure 1). The
use of chimeric mice, in which monocytes, but not the microglia
express a green ﬂuorescent protein, GFP (CX3CR1gfp >wild type
chimeras) allowed us to deﬁne the origins of the innate immune
cell populations at a site of spinal cord injury. The chimeric mice
were prepared by total body irradiation excluding the head, since
although microglial cells are radio-resistant and remain strictly
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host-derived in BM chimeras, cells of donor marrow origin have
been shown to enter irradiated brains but not of head protected
brain. In the absence of injury, blood-derived macrophages were
found to be excluded from the healthy host brain, as long as the
chimeras were created while shielding the head during the con-
ditioning irradiation. Following spinal cord injury,blood-derived
GFP+ myeloid cells were found at the lesion site; yet,the majority
of these recruited cells arrived with a delay relative to the initial
injury-associated breach of the blood–brain barrier. Secondly and
mostcritically,conditionalablationof therecruitedblood-derived
macrophages,byvirtueoftheirexpressionofCD11canduseofthe
CD11c-DTR system (Jung et al., 2002), worsened the functional
motor score of the injured animals and extended the lesion size,
while elevating the inﬂammatory response of the local microglia
(Shechter et al., 2009). Thus, the blood-derived macrophages,
are recruited to the site of the injury only following insult, and
facilitate the termination of the local immune response by dis-
playing an anti-inﬂammatory activity required for the regulation
ofthelocallyactivatedmicroglia.RecoveryfromCNSinsultshence
seems to comprise consecutive discrete phases, as proposed for
peripheral wound repair (Arnold et al., 2007; Nahrendorf et al.,
2007). Accordingly, a ﬁrst response primarily involves resident
microglia and possibly also some inﬁltrating immune cells that
“clean” the site of injury, removing dead cells, and debris. This
phaseisthenfollowedbyanactiveprocessof immunetermination
that involves resolving monocyte-derived macrophages, reminis-
cent of healing of tissues outside the CNS (Gordon and Taylor,
2005;Arnoldetal.,2007).Indeed,wefoundthatforblood-derived
macrophages to be beneﬁcial at the lesion site, they must express
IL-10,the classical anti-inﬂammatory cytokine known to be asso-
ciated with alternatively activated macrophages (also known as
“M2”or“resolving macrophages”; Shechter et al., 2009). Ablation
of the blood-derived macrophages followed by their replacement
with macrophages that are defective in IL-10 expression pre-
servesrecruitmentof cells,butresultsinimpairedoverallrecovery
(Shechteretal.,2009).Similarly,suppressingrecruitmentofinnate
immune cells at this stage is counterproductive, and is likely to
result in chronic inﬂammation and insufﬁcient repair (Shechter
etal.,2009).Conversely,boostingof monocyterecruitmentresults
in improved recovery (Shechter et al., 2009). Collectively, these
results, argue in favor of both microglia and monocyte-derived
macrophagesaskeyplayersintherepairofspinalcordinjuries,but
withnon-redundantactivity.Themonocyte-derivedmacrophages
display in this scenario a local anti-inﬂammatory and beneﬁ-
cial role, which is critically dependent upon their expression of
interleukin 10.
DIFFERENTIAL CONTRIBUTIONS OF ACTIVATED RESIDENT
MICROGLIA AND INFILTRATING MONOCYTE-DERIVED
MACROPHAGES TO EXPERIMENTALLY INDUCED
AUTOIMMUNE ENCEPHALITIS
Multiple sclerosis and its established mouse model, experimen-
tally induced autoimmune encephalitis (EAE), are characterized
by extensive CNS inﬁltration of both lymphoid and myeloid
inﬂammatory cells (Hickey, 1991). As with the acute injury
model, speciﬁc contributions or resident microglia and recruited
monocyte-derived macrophages have long remained a matter of
debate due to the absence of suitable experimental systems. Using
a combination of parabiosis and irradiation, Rossi and colleagues
recently shed considerable light on this enigma (Ajami et al.,
2011). Speciﬁcally, their strategy relied on reconstitution of an
irradiated parabiont by its shielded parabiosis partner, thereby
avoiding transfer of mechanically collected BM,which could con-
tain precursors that are not released into the circulation under
physiological conditions. This resulted in efﬁcient replacement of
BM and peripheral blood by donor cells, but no myeloid repop-
ulation of the CNS; hence this system enabled monitoring of the
dynamics of monocyte-derived macrophages and microglia dur-
ing the course of active EAE. Interestingly, signiﬁcant monocyte
recruitment via a meningal route was found only in animals that
already displayed considerable disease scores (>2). Progression
to severe EAE, strongly correlated with the extent of this myelo-
monocytic CNS inﬁltrate. Moreover, corroborating an earlier
report(Mildneretal.,2009),theuseof CCR2-deﬁcientparabionts
established monocyte-derived macrophages as active drivers of
CNS inﬂammation.
The study of Ajami et al. (2011) also allowed a glimpse at
the dynamic response of the resident microglia. Activation of
microglia, as indicated by BrdU incorporation (a measure of
proliferation), was observed prior to monocyte recruitment and
irrespective of disease progression. During the acute severe EAE
disease phase, the microglial compartment transiently expanded
but is trimmed, presumably to its original density.
Collectively, also during setting of autoimmune inﬂamma-
tion,non-redundantactivitiesofmicrogliaandmonocyte-derived
macrophages emerge. Interestingly, the monocyte-derived cells
display in this scenario as opposed to the injury model a
pro-inﬂammatory role.
CONCLUDING REMARK
The results summarized above highlight important lessons:
a. That inﬁltrating monocyte-derived macrophages are not part
of the microglia turnover.
b. The functional plasticity of monocyte-derived macrophages,
which can adopt opposite fates depending on the context
encountered.Thus,whiletheyhaveapivotalandbeneﬁcialrole
in sterile injury model, under inﬂammatory autoimmune dis-
ease conditions the recruited monocytes contribute to disease
severity.
c. The intriguing and apparently distinct roles of resident
microglia, the brain sentinels: on one hand, their essential role
in the ﬁrst phase of recovery from sterile injury, and, on the
other hand, their key contribution in the initiation of inﬂam-
mation autoimmune disease possibly through their interaction
with autoreactive CD4+ T cells.
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